FEBS Letters
Volume 581, Issue 26 , Pages 5099-5104, 30 October 2007

Phenotypic behavior of C2C12 myoblasts upon expression of the dystrophy-related caveolin-3 P104L and TFT mutants

Edited by Horst Feldmann

  • Alessandro Fanzani

      Affiliations

    • Department of Biomedical Sciences and Biotechnology, Unit of Biochemistry, University of Brescia, Viale Europa 11, 25123 Brescia, Italy
    • Corresponding Author InformationCorresponding author. Fax: +39 030 3701157.
  • ,
  • Elena Stoppani

      Affiliations

    • Department of Biomedical Sciences and Biotechnology, Unit of Biochemistry, University of Brescia, Viale Europa 11, 25123 Brescia, Italy
  • ,
  • Laura Gualandi

      Affiliations

    • Department of Biomedical Sciences and Biotechnology, Unit of General Pathology, University of Brescia, Italy
  • ,
  • Roberta Giuliani

      Affiliations

    • Department of Biomedical Sciences and Biotechnology, Unit of Biochemistry, University of Brescia, Viale Europa 11, 25123 Brescia, Italy
  • ,
  • Ferruccio Galbiati

      Affiliations

    • Department of Pharmacology, University of Pittsburgh School of Medicine, Pittsburgh PA, USA
  • ,
  • Stefania Rossi

      Affiliations

    • Department of Biomedical Sciences and Biotechnology, Unit of Biochemistry, University of Brescia, Viale Europa 11, 25123 Brescia, Italy
  • ,
  • Anna Fra

      Affiliations

    • Department of Biomedical Sciences and Biotechnology, Unit of Pathology and Immunology, University of Brescia, Italy
  • ,
  • Augusto Preti

      Affiliations

    • Department of Biomedical Sciences and Biotechnology, Unit of Biochemistry, University of Brescia, Viale Europa 11, 25123 Brescia, Italy
  • ,
  • Sergio Marchesini

      Affiliations

    • Department of Biomedical Sciences and Biotechnology, Unit of Biochemistry, University of Brescia, Viale Europa 11, 25123 Brescia, Italy

Received 25 June 2007; received in revised form 19 September 2007; accepted 26 September 2007. published online 04 October 2007.

Abstract 

Caveolin-3 (Cav-3) is the main scaffolding protein present in myofiber caveolae. We transfected C2C12 myoblasts with dominant negative forms of Cav-3, P104L or ΔTFT, respectively, which cause the limb-girdle muscular dystrophy 1-C. Both these forms triggered Cav-3 loss during C2C12 cell differentiation. The P104L mutation reduced myofiber formation by impaired AKT signalling, accompanied by dramatic expression of the E3 ubiquitin ligase Atrogin. On the other hand, the ΔTFT mutation triggered hypertrophic myotubes sustained by prolonged AKT activation, but independent of increased levels of follistatin and interleukin 4 expression. These data suggest that separated mutations within the same dystrophy-related gene may cause muscle degeneration through different mechanisms.

Abbreviations: DMEM, Dulbecco’s modified Eagle’s medium, FBS, fetal bovine serum, HS, horse serum, MHC, myosin heavy chain, NFATC, nuclear factor of activated T-cells, IL-4, Interleukin 4

Keywords: Caveolin 3, Dystrophy, AKT, Follistatin, NFATC2, IL-4, Murf-1, Atrogin

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0014-5793(07)01039-3

doi:10.1016/j.febslet.2007.09.055

FEBS Letters
Volume 581, Issue 26 , Pages 5099-5104, 30 October 2007